Dupuytren's Contracture of the Hand (Viking's Disease)

DBCOND0091896Musculoskeletal and Connective Tissue Diseases Neoplasms

Dupuytren's Contracture of the Hand (Viking's Disease) is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as: Dupuytren Contracture · Dupuytren's Contracture · Dupuytren's Disease · Dupuytrens Contracture · Dupuytren Disease
Classified under: Musculoskeletal and Connective Tissue Diseases
Neoplasms
Indicated drugs: Collagenase clostridium histolyticum

Resolves to

Vocabularies

MeSHM000615075ICD-10M72.0SNOMED CT156724004MedDRA10010818UMLSC0013312

What you can answer from here — as of October 30, 2026

1Indicated drugWith each drug's targets and mechanism

Listed above

1Structured indicationPopulation, line of therapy, route and combination as fields, not prose

41Clinical trialsPhase, status and sponsor resolved per trial

2Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Dupuytren's Contracture of the Hand (Viking's Disease) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account